申请人:Pfizer Inc.
公开号:US04432970A1
公开(公告)日:1984-02-21
6-beta-Halopenicillanic acid 1,1-dioxides, physiologically acceptable salts thereof and esters thereof readily hydrolyzable; pharmaceutical compositions containing a 6-beta-halopenicillanic acid 1,1-dioxide, a physiologically acceptable salt thereof or an ester thereof readily hydrolyzable; and a method for enhancing the effectiveness of a beta-lactam antibiotic, using a 6-beta-halopenicillanic acid 1,1-dioxide, a physiologically acceptable salt thereof or an ester thereof readily hydrolyzable.
6-β-卤代苯乙酸1,1-二氧化物,其生理可接受盐及其易于水解的酯;含有6-β-卤代苯乙酸1,1-二氧化物,其生理可接受盐或其易于水解的酯的药物组合物;以及使用6-β-卤代苯乙酸1,1-二氧化物,其生理可接受的盐或易于水解的酯来增强β-内酰胺抗生素效果的方法。